Integrum
Slipp dessa annonser och få en massa andra godsaker med vårt
premiumabonnemang.
Integrum's OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations
The clinical study will be important for the future approval of the OPRA™ Implant System on the below-knee amputation level, which is the most frequent amputation level. The study will be performed by the Walter Reed National Military Medical Center.
"This is an important milestone in the expansion of indications for our OPRA™ Implant System." said Rickard Brånemark, CEO of Integrum.
| Datum | 2023-10-30, kl 08:32 |
| Källa | Cision |